tiprankstipranks
Chugai Pharmaceutical Co Ltd (JP:4519)
:4519
Japanese Market
4519
Chugai Pharmaceutical Co
RESEARCH TOOLSreports
Want to see JP:4519 full AI Analyst Report?

Chugai Pharmaceutical Co (4519) Income Statement

4 Followers

Chugai Pharmaceutical Co Income Statement

Last quarter (Q1 2026), Chugai Pharmaceutical Co's total revenue was ¥321.75B, an increase of 11.54% from the same quarter last year. In Q1, Chugai Pharmaceutical Co's net income was ¥115.42B. See Chugai Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 1.26T¥ 1.17T¥ 1.11T¥ 1.26T¥ 999.76B
Gross Profit
¥ 894.25B¥ 830.75B¥ 693.01B¥ 783.06B¥ 660.27B
Operating Expenses
¥ 304.06B¥ 286.84B¥ 277.34B¥ 249.12B¥ 226.53B
Depreciation and Amortization
¥ 32.53B¥ 31.66B¥ 31.74B¥ 31.43B¥ 30.87B
EBITDA
¥ 631.37B¥ 574.80B¥ 475.64B¥ 562.66B¥ 450.30B
Operating Income
¥ 590.19B¥ 543.91B¥ 415.67B¥ 533.94B¥ 433.74B
Other Income/Expenses
¥ 7.62B¥ -873.00M¥ 28.16B¥ -2.78B¥ -14.35B
Pretax Income
¥ 597.81B¥ 543.03B¥ 443.82B¥ 531.17B¥ 419.38B
Net Income
¥ 434.01B¥ 387.32B¥ 325.47B¥ 374.43B¥ 303.00B
Per Share Metrics
Basic EPS
¥ 263.73¥ 235.39¥ 197.83¥ 227.64¥ 184.29
Diluted EPS
¥ 263.72¥ 235.36¥ 197.80¥ 227.57¥ 184.17
Weighted Average Shares Outstanding
 1.65B 1.65B 1.65B 1.64B 1.64B
Weighted Average Shares Outstanding (Diluted)
 1.65B 1.65B 1.65B 1.65B 1.65B
Currency in JPY

Chugai Pharmaceutical Co Earnings and Revenue History